Regimes for protecting pharmaceutical and biotechnological products via patents are slowly but steadily improving in many Latin American countries. Managing IP invited Alejandro Luna of Olivares & Cia, Guillermo Carey of HarneckerCarey Carey y CÃa and in-house counsel Regina Kuchle to discuss some promising developments and continuing challenges
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
Leaders at US law firms explain what attorneys can learn from AI cases involving Meta and Anthropic, and why the outcomes could guide litigation strategies